Stockreport

AGIO's Q3 Earnings Miss Mark, Revenues In Line, Stock Down [Yahoo! Finance]

Royalty Pharma plc - Class A Ordinary Shares  (RPRX) 
US:NASDAQ Investor Relations: ir.reprosrx.com/investor-relations
PDF In the year-ago quarter, the company had reported a loss of $1.64 per share. The abovementioned earnings included a gain on the sale of contingent payments and a miles [Read more]